Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wp-cerber domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /www/htdocs/w00e14a1/CPC-NEU2021/wp-includes/functions.php on line 6114
{"id":8871,"date":"2021-08-16T11:52:11","date_gmt":"2021-08-16T09:52:11","guid":{"rendered":"https:\/\/www.chameleon-pharma.com\/the-philippines-regulatory-affairs\/"},"modified":"2024-04-09T14:22:09","modified_gmt":"2024-04-09T12:22:09","slug":"the-philippines-regulatory-affairs","status":"publish","type":"page","link":"https:\/\/www.chameleon-pharma.com\/ru\/services\/pharma-regulatory-registration\/the-philippines-regulatory-affairs\/","title":{"rendered":"The Philippines — Regulatory Affairs"},"content":{"rendered":"

[et_pb_section fb_built=»1″ admin_label=»Header» _builder_version=»4.16″ _module_preset=»default» background_color=»rgba(0,19,137,0.67)» background_image=»https:\/\/www.chameleon-pharma.com\/wp-content\/uploads\/andreas-brucker-g5Uh7nP60FA-unsplash-1-scaled.jpg» background_blend=»color» height=»200px» max_height=»200px» custom_margin=»-15px||||false|false» custom_padding=»||||false|false» locked=»off» global_colors_info=»{}»][et_pb_row make_equal=»on» custom_padding_last_edited=»on|tablet» _builder_version=»4.16″ _module_preset=»default» custom_margin=»0px||||false|false» custom_padding=»||||false|false» custom_padding_tablet=»0px||0px||true|false» custom_padding_phone=»0px||0px||true|false» global_colors_info=»{}»][et_pb_column type=»4_4″ _builder_version=»4.16″ _module_preset=»default» custom_css_main_element=»margin: auto;» global_colors_info=»{}»][et_pb_text _builder_version=»4.16″ _module_preset=»default» header_font=»|700|||||||» header_text_color=»#FFFFFF» header_font_size=»45px» header_font_size_tablet=»45px» header_font_size_phone=»35px» header_font_size_last_edited=»on|phone» global_colors_info=»{}»]<\/p>\n

The Philippines — Regulatory Affairs<\/span><\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=»1″ _builder_version=»4.16″ _module_preset=»default» locked=»off» global_colors_info=»{}»][et_pb_row _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_column type=»4_4″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_cta _builder_version=»4.16″ _module_preset=»default» background_color=»#0B0B7A» custom_padding=»||0px|||» global_colors_info=»{}»]<\/p>\n

Within the ASEAN region, the Philippines is the third most attractive Pharma market. Overall, the Filipino Pharma market is still relatively dependent on foreign manufacturers, meaning that there is plenty of opportunity for foreign companies seeking to enter this growing market.<\/p>\n

[\/et_pb_cta][et_pb_cta title=»Regulatory Body — Food and Drug Administration of the Philippines» _builder_version=»4.16″ _module_preset=»default» header_text_color=»#000000″ body_text_color=»#000000″ background_color=»#bbccee» global_colors_info=»{}»]<\/p>\n

The regulatory bodies in the Philippines responsible for the registrations of drug products and medical devices is called the Food and Drug Administration of the Philippines (FDA).<\/a><\/p>\n

[\/et_pb_cta][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=»1″ _builder_version=»4.16″ _module_preset=»default» min_height=»906px» custom_margin=»-72px|||||» custom_padding=»||20px|||» locked=»off» global_colors_info=»{}»][et_pb_row column_structure=»1_2,1_2″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_column type=»1_2″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_text _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»]<\/p>\n

Pharma Prescription Drugs<\/h2>\n

To be distributed in the Philippines, companies must first obtain a license to operate<\/strong> and a certificate of product registration from the FDA. After obtaining a license to operate, companies must apply for a certificate of product registration to have their products examined and registered with the FDA.<\/strong> However, the requirements for application for the certificate of product registration vary depending on the status of the product as a new drug or a generic.<\/strong><\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=»1_2″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_text _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»]<\/p>\n

Consumer Healthcare Drugs\/OTC<\/h2>\n

OTC drugs and prescription drugs for distribution are subject to similar registration processes.<\/strong> Companies must still receive a licence to operate before applying for a certificate of product registration.<\/strong> However, for many OTC preparations and household remedy products, the application dossier is amended and much shorter<\/strong> than for prescription drugs. With our long-term experience and network with the DAV, we can offer a relatively fast registration process for Consumer Healthcare & OTC drugs in the Philippines.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=»1_2,1_2″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_column type=»1_2″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_text _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»]<\/p>\n

Medical Devices<\/h2>\n

In the Philippines, medical devices are divided into four type \u2013 Classes A, B, C, and D<\/strong> based on their level of risk. The rules for device classifications are quite specific and can vary greatly depending on different criteria. All medical devices imported into the Philippines are required to register for a Certificate of Medical Device Notification (CMDN)<\/strong> if they are Class A devices, or a Certificate of Medical Device Registration (CMDR) if they are Class B to D. The registration processes for obtaining the certificate vary depending on the class of the medical device.<\/strong><\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=»1_2″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_text _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»]<\/p>\n

Food Supplements\/Nutraceuticals<\/h2>\n

Food supplements and nutraceuticals in the Philippines are regulated by the FDA. <\/strong>All companies seeking to import and manufacture food products including supplements in the Philippines must first obtain a License to Operate (LTO). For importers, they must have a certificate of distributorship and must also have accurate stability and safety data.<\/p>\n

 <\/p>\n

 <\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=»1_2,1_2″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_column type=»1_2″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_text _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»]<\/p>\n

Cosmetics and Derma<\/h2>\n

Similar to other medical devices or drug products, all cosmetic companies in the Philippines<\/strong> must obtain a License to Operate from the FDA prior to engaging in manufacturing, importing, distribution and sale of cosmetics.<\/strong> Unlike other medical products, cosmetics only require an application for a Notification of Cosmetic Product from the FDA, which is simpler than applications for the Certificate of Product Registration.<\/p>\n

 <\/p>\n

 <\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=»1_2″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_image src=»https:\/\/www.chameleon-pharma.com\/wp-content\/uploads\/Philippine.avif» alt=»A building in Manila, the Philippines with the national flags » title_text=»Regulatory Affairs in the Philippines» _builder_version=»4.22.2″ _module_preset=»default» hover_enabled=»0″ global_colors_info=»{}» sticky_enabled=»0″][\/et_pb_image][et_pb_text _builder_version=»4.22.2″ _module_preset=»default» text_font_size=»10px» min_height=»41px» custom_margin=»-37px|||||» hover_enabled=»0″ global_colors_info=»{}» sticky_enabled=»0″]<\/p>\n

Photo by <\/span>Mara Rivera<\/a> on <\/span>Unsplash<\/a><\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=»1″ admin_label=»Tabs» _builder_version=»4.16″ _module_preset=»default» custom_margin=»-83px|||||» locked=»off» global_colors_info=»{}»][et_pb_row _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_column type=»4_4″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_text _builder_version=»4.16″ _module_preset=»default» locked=»off» global_colors_info=»{}»]<\/p>\n

Frequently Asked Questions from clients — Regulatory Affairs<\/h2>\n

[\/et_pb_text][et_pb_tabs _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_tab title=»FAQ — Prescription Products» _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»]<\/p>\n